IL ‐1 receptor antagonist anakinra downregulates inflammatory cytokines during renal normothermic machine perfusion: Preliminary results
Artificial Organs · 2025
DOI: 10.1111/aor.14909 ↗Kurz gefasst
Fachartikel in der Zeitschrift Artificial Organs, 2025. Verfasst von Sarah A Hosgood und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK. Hauptthemen laut MEDLINE: Interleukin 1 Receptor Antagonist Protein, Perfusion, Kidney, Cytokines. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stoneygate Trust.
Abstract (Originalsprache)
Background
The interleukin 1 (IL‐1) cytokine group plays a key role in sterile inflammation and may be an important target for transplant‐related renal injury. This study examined the effects of anakinra, a non‐specific IL‐1 receptor antagonist, administered during normothermic machine perfusion (NMP) of porcine kidneys.
Method
Paired porcine kidneys ( n = 5 pairs) underwent 15 min of warm ischemia plus 2 h of static cold storage in ice. Kidneys were then perfused with autologous whole blood using an ex vivo NMP platform. Kidneys were randomly allocated to receive anakinra or vehicle administered at the start of NMP. Cortical biopsies were collected at baseline before ischemic injury and at the end of NMP. Functional parameters were recorded and calculated, and inflammatory markers were measured by qPCR and ELISA techniques.
Results
During NMP, there were no statistically significant differences in renal blood flow, urine output, creatinine clearance or fractional excretion of sodium in the anakinra and control groups. The administration of anakinra significantly downregulated transcriptional expression of IL‐6, Fas ligand and intercellular adhesion molecule 1 ( p = 0.029, 0.029, 0.028, respectively).
Conclusion
Anakinra, an IL‐1 receptor blocker, successfully attenuated the downstream inflammatory and immune‐mediated response within the kidney during NMP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.
ORCID-Profile: Sarah A Hosgood
Förderung
- Stoneygate Trust
Zitieren
APA
Hosgood, S. A., Moore, T., Walker, A., & Nicholson, M. L. (2025). IL ‐1 receptor antagonist anakinra downregulates inflammatory cytokines during renal normothermic machine perfusion: Preliminary results. Artificial Organs. https://doi.org/10.1111/aor.14909
Vancouver
Hosgood SA, Moore T, Walker A, Nicholson ML. IL ‐1 receptor antagonist anakinra downregulates inflammatory cytokines during renal normothermic machine perfusion: Preliminary results. Artificial Organs. 2025. doi:10.1111/aor.14909
BibTeX
@article{Hosgood2025,
author = {Hosgood, Sarah A and Moore, Tom and Walker, Alex and Nicholson, Michael L},
title = {IL ‐1 receptor antagonist anakinra downregulates inflammatory cytokines during renal normothermic machine perfusion: Preliminary results},
journal = {Artificial Organs},
year = {2025},
doi = {10.1111/aor.14909}
}
EUVIMED